TABLE 6.
Average out-of-pocket payment (OPP) and total payment for one tablet of selected drugs
| Drug name and strength | Brand/Generic | OPP | Total payment | OPP, private insurance | OPP, Medicaid | OPP, Medicare | OPP, no insurance |
|---|---|---|---|---|---|---|---|
| Anti-Depressants | |||||||
|
| |||||||
| Prozac 20 mg | Brand | 0.82 | 2.98 | 0.27 | 0.06 | 0.84 | 1.94 |
| Fluoxetine 20 mg | Generic | 0.36 | 0.90 | 0.25 | 0.02 | 0.09 | 0.76 |
| Paxil 20 mg | Brand | 0.80 | 1.69 | 0.52 | 0.09 | 0.10 | 1.43 |
| Paroxetine 20 mg | Generic | 0.26 | 0.83 | 0.30 | 0.03 | 0.09 | 0.50 |
| Zoloft 100 mg | Brand | 1.11 | 2.30 | 0.67 | 0.10 | 0.32 | 2.51 |
| Sertraline 100 mg | Generic | 0.24 | 0.78 | 0.24 | 0.05 | 0.12 | 0.52 |
| Celexa 20 mg | Brand | 0.64 | 1.66 | 0.61 | 0.08 | 0.20 | 1.73 |
| Citalopram 20 mg | Generic | 0.23 | 0.59 | 0.25 | 0.04 | 0.11 | 0.36 |
| Lexapro 20 mg | Brand | 1.30 | 4.32 | 1.44 | 0.04 | 0.45 | 3.90 |
| Escitalopram 20 mg | Generic | 0.40 | 3.19 | 0.46 | 0.08 | 0.36 | 0.65 |
|
| |||||||
| PPIs | |||||||
|
| |||||||
| Prevacid 30 mg | Brand | 1.09 | 5.50 | 0.84 | 0.03 | 0.48 | 5.74 |
| Lansoprazole 30 mg | Generic | 0.35 | 2.27 | 0.27 | 0.02 | 0.21 | 1.72 |
| Prilosec 20 mg | Brand | 0.42 | 1.24 | 0.32 | 0.03 | 0.14 | 1.63 |
| Omeprazole 20 mg | Generic | 0.31 | 1.13 | 0.23 | 0.06 | 0.12 | 1.11 |
|
| |||||||
| Statins | |||||||
|
| |||||||
| Pravachol 40 mg | Brand | 1.24 | 3.58 | 0.51 | 0.02 | 0.50 | 3.43 |
| Pravastatin 40 mg | Generic | 0.23 | 0.74 | 0.19 | 0.04 | 0.11 | 0.44 |
| Zocor 20 mg | Brand | 1.18 | 3.59 | 0.44 | 0.05 | 0.29 | 4.55 |
| Simvastatin 20 mg | Generic | 0.27 | 0.91 | 0.22 | 0.04 | 0.14 | 0.62 |
|
| |||||||
| All | |||||||
|
| |||||||
| All brand name drugs | 0.95 | 2.99 | 0.62 | 0.06 | 0.37 | 2.98 | |
| All generic drugs | 0.29 | 1.26 | 0.27 | 0.04 | 0.15 | 0.74 | |
| Average difference between brand and generic | 0.66 | 1.73 | 0.36 | 0.01 | 0.22 | 2.24 | |
The out-of-pocket payment (OPP) and total payment are calculated for a purchase of one tablet of each drug’s most common strength using MEPS data in the years 2006-2012.